BCYC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Bicycle Therapeutics Plc (BCYC).


$966.64M Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

BCYC Market Cap. (MRY)


BCYC Shares Outstanding (MRY)


BCYC Assets (MRY)


Total Assets

$956.87M

Total Liabilities

$163.81M

Total Investments

$0

BCYC Income (MRY)


Revenue

$35.27M

Net Income

-$169.03M

Operating Expense

$245.15M

BCYC Cash Flow (MRY)


CF Operations

-$164.72M

CF Investing

-$1.24M

CF Financing

$519.75M

BCYC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BCYC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$956,868,000 (60.73%)

$595,344,000 (44.99%)

$410,609,000 (-14.42%)

$479,792,000 (197.73%)

Assets Current

$928,605,000 (65.27%)

$561,868,000 (52.11%)

$369,383,000 (-19.45%)

$458,555,000 (194.47%)

Assets Non-Current

$28,263,000 (-15.57%)

$33,476,000 (-18.80%)

$41,226,000 (94.12%)

$21,237,000 (291.18%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$793,060,000 (113.80%)

$370,932,000 (36.98%)

$270,783,000 (-21.80%)

$346,254,000 (262.72%)

Property Plant & Equipment Net

$17,189,000 (-37.91%)

$27,684,000 (-15.52%)

$32,768,000 (84.20%)

$17,789,000 (393.18%)

Cash & Equivalents

$879,520,000 (67.07%)

$526,423,000 (55.22%)

$339,154,000 (-22.69%)

$438,680,000 (222.58%)

Accumulated Other Comprehensive Income

$119,000 (109.13%)

-$1,304,000 (-436.95%)

$387,000 (111.42%)

-$3,388,000 (-6.11%)

Deferred Revenue

$101,658,000 (-24.81%)

$135,194,000 (118.50%)

$61,873,000 (-13.27%)

$71,340,000 (102.92%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$35,653,000 (48.31%)

$24,039,000 (13.35%)

$21,207,000 (78.06%)

$11,910,000 (-18.61%)

Trade & Non-Trade Payables

$15,793,000 (21.02%)

$13,050,000 (101.64%)

$6,472,000 (137.85%)

$2,721,000 (99.34%)

Accumulated Retained Earnings (Deficit)

-$680,791,000 (-33.03%)

-$511,760,000 (-54.57%)

-$331,096,000 (-51.62%)

-$218,379,000 (-44.09%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,990,000 (-90.04%)

$40,080,000 (-2.72%)

$41,200,000 (-1.80%)

$41,954,000 (180.99%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$3,990,000 (-90.04%)

$40,080,000 (-2.72%)

$41,200,000 (-1.80%)

$41,954,000 (180.99%)

Total Liabilities

$163,808,000 (-27.01%)

$224,412,000 (60.49%)

$139,826,000 (4.71%)

$133,538,000 (103.28%)

Liabilities Current

$67,230,000 (-3.32%)

$69,537,000 (30.36%)

$53,342,000 (47.20%)

$36,238,000 (56.68%)

Liabilities Non-Current

$96,578,000 (-37.64%)

$154,875,000 (79.08%)

$86,484,000 (-11.12%)

$97,300,000 (128.60%)

BCYC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$35,275,000 (30.76%)

$26,976,000 (86.52%)

$14,463,000 (23.65%)

$11,697,000 (12.58%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$72,181,000 (19.45%)

$60,426,000 (22.06%)

$49,507,000 (52.63%)

$32,435,000 (11.07%)

Research & Development Expense

$172,966,000 (10.52%)

$156,496,000 (91.76%)

$81,609,000 (81.84%)

$44,880,000 (35.39%)

Operating Expenses

$245,147,000 (13.01%)

$216,922,000 (65.44%)

$131,116,000 (69.59%)

$77,315,000 (24.00%)

Interest Expense

$1,730,000 (-46.98%)

$3,263,000 (-2.42%)

$3,344,000 (12.06%)

$2,984,000 (552.95%)

Income Tax Expense

-$4,765,000 (-427.04%)

$1,457,000 (195.60%)

-$1,524,000 (8.36%)

-$1,663,000 (-129.70%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$169,031,000 (6.44%)

-$180,664,000 (-60.28%)

-$112,717,000 (-68.69%)

-$66,819,000 (-30.99%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$169,031,000 (6.44%)

-$180,664,000 (-60.28%)

-$112,717,000 (-68.69%)

-$66,819,000 (-30.99%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$169,031,000 (6.44%)

-$180,664,000 (-60.28%)

-$112,717,000 (-68.69%)

-$66,819,000 (-30.99%)

Weighted Average Shares

$58,207,593 (63.54%)

$35,592,362 (20.00%)

$29,660,659 (18.35%)

$25,061,734 (30.90%)

Weighted Average Shares Diluted

$58,207,593 (63.54%)

$35,592,362 (20.00%)

$29,660,659 (18.35%)

$25,061,734 (30.90%)

Earning Before Interest & Taxes (EBIT)

-$172,066,000 (2.20%)

-$175,944,000 (-58.66%)

-$110,897,000 (-69.31%)

-$65,498,000 (-27.73%)

Gross Profit

$35,275,000 (30.76%)

$26,976,000 (86.52%)

$14,463,000 (23.65%)

$11,697,000 (12.58%)

Operating Income

-$209,872,000 (-10.49%)

-$189,946,000 (-62.83%)

-$116,653,000 (-77.78%)

-$65,618,000 (-26.29%)

BCYC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,235,000 (57.84%)

-$2,929,000 (84.57%)

-$18,987,000 (-835.32%)

-$2,030,000 (-69.17%)

Net Cash Flow from Financing

$519,750,000 (107.88%)

$250,027,000 (3636.21%)

$6,692,000 (-97.91%)

$320,725,000 (410.36%)

Net Cash Flow from Operations

-$164,724,000 (-171.70%)

-$60,628,000 (29.59%)

-$86,111,000 (-482.07%)

-$14,794,000 (16.84%)

Net Cash Flow / Change in Cash & Cash Equivalents

$353,097,000 (88.00%)

$187,816,000 (288.71%)

-$99,526,000 (-132.88%)

$302,690,000 (589.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,235,000 (57.84%)

-$2,929,000 (84.57%)

-$18,987,000 (-835.32%)

-$2,030,000 (-69.17%)

Issuance (Repayment) of Debt Securities

-$31,905,000 (0%)

$0 (0%)

$0 (0%)

$15,000,000 (3.97%)

Issuance (Purchase) of Equity Shares

$551,655,000 (120.64%)

$250,027,000 (3636.21%)

$6,692,000 (-97.81%)

$305,725,000 (531.45%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$694,000 (-151.56%)

$1,346,000 (220.18%)

-$1,120,000 (7.51%)

-$1,211,000 (-6473.68%)

Share Based Compensation

$38,081,000 (17.26%)

$32,477,000 (21.28%)

$26,779,000 (121.63%)

$12,083,000 (85.49%)

Depreciation Amortization & Accretion

$7,174,000 (9.59%)

$6,546,000 (77.45%)

$3,689,000 (161.82%)

$1,409,000 (10.34%)

BCYC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-479.20% (28.45%)

-669.70% (14.06%)

-779.30% (-36.43%)

-571.20% (-16.33%)

EBITDA Margin

-467.40% (25.57%)

-628.00% (15.28%)

-741.30% (-35.30%)

-547.90% (-13.86%)

Return on Average Equity (ROAE)

-23.70% (59.00%)

-57.80% (-54.13%)

-37.50% (-12.28%)

-33.40% (41.40%)

Return on Average Assets (ROAA)

-19.00% (44.28%)

-34.10% (-31.15%)

-26.00% (-17.65%)

-22.10% (37.22%)

Return on Sales (ROS)

-487.80% (25.21%)

-652.20% (14.95%)

-766.80% (-36.93%)

-560.00% (-13.48%)

Return on Invested Capital (ROIC)

-323.70% (-32.45%)

-244.40% (-37.54%)

-177.70% (0.39%)

-178.40% (60.62%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.83 (-35.66%)

-3.56 (54.31%)

-7.79 (65.83%)

-22.8 (-237.85%)

Price to Sales Ratio (P/S)

23.1 (-3.16%)

23.86 (-60.70%)

60.7 (-53.45%)

130.42 (294.29%)

Price to Book Ratio (P/B)

1.22 (-41.05%)

2.07 (-36.27%)

3.25 (-37.21%)

5.17 (29.01%)

Debt to Equity Ratio (D/E)

0.21 (-65.79%)

0.6 (17.25%)

0.52 (33.68%)

0.39 (-43.90%)

Earnings Per Share (EPS)

-2.9 (42.91%)

-5.08 (-33.68%)

-3.8 (-42.32%)

-2.67 (-0.38%)

Sales Per Share (SPS)

0.61 (-20.05%)

0.76 (55.33%)

0.49 (4.50%)

0.47 (-14.00%)

Free Cash Flow Per Share (FCFPS)

-2.85 (-59.63%)

-1.79 (49.59%)

-3.54 (-428.02%)

-0.67 (32.36%)

Book Value Per Share (BVPS)

13.63 (30.73%)

10.42 (14.16%)

9.13 (-33.92%)

13.82 (177.10%)

Tangible Assets Book Value Per Share (TABVPS)

16.44 (-1.72%)

16.73 (20.82%)

13.84 (-27.68%)

19.14 (127.44%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (80.00%)

-5 (79.17%)

-24 (-380.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.49 (64.61%)

-1.39 (73.26%)

-5.21 (78.63%)

-24.38 (-392.17%)

Asset Turnover

0.04 (-21.57%)

0.05 (54.55%)

0.03 (-15.38%)

0.04 (-45.83%)

Current Ratio

13.81 (70.94%)

8.08 (16.68%)

6.92 (-45.27%)

12.65 (87.94%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$165,959,000 (-161.12%)

-$63,557,000 (39.53%)

-$105,098,000 (-524.69%)

-$16,824,000 (11.40%)

Enterprise Value (EV)

$81,315,294 (-65.53%)

$235,922,588 (-57.76%)

$558,568,342 (-64.25%)

$1,562,284,287 (530.84%)

Earnings Before Tax (EBT)

-$173,796,000 (3.02%)

-$179,207,000 (-56.87%)

-$114,241,000 (-66.82%)

-$68,482,000 (-32.37%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$164,892,000 (2.66%)

-$169,398,000 (-58.01%)

-$107,208,000 (-67.28%)

-$64,089,000 (-28.18%)

Invested Capital

$14,108,000 (-64.25%)

$39,464,000 (-33.46%)

$59,313,000 (26.66%)

$46,828,000 (176.04%)

Working Capital

$861,375,000 (74.96%)

$492,331,000 (55.78%)

$316,041,000 (-25.16%)

$422,317,000 (218.50%)

Tangible Asset Value

$956,868,000 (60.73%)

$595,344,000 (44.99%)

$410,609,000 (-14.42%)

$479,792,000 (197.73%)

Market Capitalization

$966,644,294 (26.03%)

$766,981,588 (-12.72%)

$878,808,342 (-50.89%)

$1,789,560,287 (367.96%)

Average Equity

$713,488,250 (128.28%)

$312,553,500 (4.02%)

$300,476,750 (50.01%)

$200,304,500 (123.90%)

Average Assets

$889,528,000 (68.07%)

$529,249,500 (22.17%)

$433,200,500 (43.09%)

$302,753,750 (109.12%)

Invested Capital Average

$53,156,250 (-26.18%)

$72,004,750 (15.41%)

$62,390,000 (69.96%)

$36,708,000 (224.32%)

Shares

69,046,021 (62.76%)

42,421,548 (42.88%)

29,689,471 (0.99%)

29,399,709 (38.00%)